Legend Biotech to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Legend Biotech Corporation (NASDAQ: LEGN) will participate in the 42nd annual J.P. Morgan Healthcare Conference. Ying Huang, Ph.D., the company’s CEO, will deliver the presentation on Tuesday, January 9, 2024, at 2:15 p.m. PT. The live audio webcast will be available on Legend’s website.

SOMERSET, N.J.--(BUSINESS WIRE)-- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing, and commercializing novel therapies to treat life-threatening diseases, today announced its participation in the 42^nd annual J.P. Morgan Healthcare Conference in San Francisco, CA. Ying Huang, Ph.D., the company’s chief executive officer, will deliver the company presentation on Tuesday, January 9, 2024, at 2:15 p.m. PT.

The live audio webcast will be available to investors and other interested parties by accessing the Investor Relations section of Legend’s website. The audio webcast replay will be available approximately 48-hrs after the webcast.

About Legend Biotech

Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of cutting-edge therapeutics for patients worldwide.

Learn more at https://legendbiotech.com/ and follow us on X (formerly Twitter) and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240102013797/en/

Investor:

Jessie Yeung, Head of Investor Relations & Public Relations, Legend Biotech

jessie.yeung@legendbiotech.com

Press:

Alexandra Ventura, Manager, Corporate Communications & Investor Relations, Legend Biotech

alex.ventura@legendbiotech.com

732-850-5598

Source: Legend Biotech Corporation

FAQ

What is Legend Biotech Corporation's ticker symbol?

The ticker symbol for Legend Biotech Corporation is LEGN.

When will the CEO of Legend Biotech Corporation deliver the company presentation at the J.P. Morgan Healthcare Conference?

Ying Huang, Ph.D., the CEO of Legend Biotech Corporation, will deliver the company presentation on Tuesday, January 9, 2024, at 2:15 p.m. PT.

Where can investors access the live audio webcast of Legend Biotech Corporation's presentation at the conference?

Investors and other interested parties can access the live audio webcast by visiting the Investor Relations section of Legend Biotech Corporation's website.

When will the audio webcast replay of Legend Biotech Corporation's presentation be available?

The audio webcast replay will be available approximately 48 hours after the webcast.